Cite Filings / ACAD / 0002100121-26-000077
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

ACADIA PHARMACEUTICALS INC · Filed 2026-04-28 · Acc 0002100121-26-000077

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-08-07 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-05-05 4 EVP, CHIEF FINANCIAL OFFICER sold 3,506 shares at $21.79 ($76,396)
  • 2026-05-05 4 PRINCIPAL ACCOUNTING OFFICER sold 1,332 shares at $21.79 ($29,024)
  • 2026-05-01 8-K Executive or director change · Regulation FD disclosure
  • 2026-04-28 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-04-24 ARS Annual Report to Security Holders
  • 2026-04-24 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…